Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05448274Completed
Randomised, double-blind trial in Overweight. Primary endpoint: Matsuda Insulin Sensitivity Index at 2 hours. Started May 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05448274.